General Information of Drug (ID: DM56TVA)

Drug Name
5-oxo-ODE Drug Info
Synonyms 5-oxo-(6E,8Z)-octadecadienoic acid
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
71751402
ChEBI ID
CHEBI:137754
CAS Number
CAS 1021188-25-9
TTD Drug ID
DM56TVA

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
5S-HETE DM3Z6G4 Discovery agent N.A. Investigative [3]
5S-HPETE DME1304 Discovery agent N.A. Investigative [3]
5-oxo-C20:3 DM6FSUW Discovery agent N.A. Investigative [4]
5-(6-chloro-2-hexyl-1H-indol-1-yl)-5-oxo-valeric acid DM0K7U5 Discovery agent N.A. Investigative [5]
5-oxo-12-HETE DMLABR9 Discovery agent N.A. Investigative [6]
5-oxo-15-HETE DM9ZC7B Discovery agent N.A. Investigative [7]
Gue1654 DM89KNT Discovery agent N.A. Investigative [8]
[3H]5-oxo-ETE DM50WFM Discovery agent N.A. Investigative [9]
5-oxo-20-HETE DM493GU Discovery agent N.A. Investigative [7]
⏷ Show the Full List of 9 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Oxoeicosanoid receptor 1 (OXER1) TT7WBSV OXER1_HUMAN Agonist [2]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6164).
2 Human neutrophils convert the sebum-derived polyunsaturated fatty acid Sebaleic acid to a potent granulocyte chemoattractant. J Biol Chem. 2008 Apr 25;283(17):11234-43.
3 TG1019/OXE, a Galpha(i/o)-protein-coupled receptor, mediates 5-oxo-eicosatetraenoic acid-induced chemotaxis. Biochem Biophys Res Commun. 2005 Sep 9;334(4):987-95.
4 Structural requirements for activation of the 5-oxo-6E,8Z, 11Z,14Z-eicosatetraenoic acid (5-oxo-ETE) receptor: identification of a mead acid metabolite with potent agonist activity. J Pharmacol Exp Ther. 2008 May;325(2):698-707.
5 5-Oxo-ETE receptor antagonists. J Med Chem. 2013 May 9;56(9):3725-32.
6 Biological inactivation of 5-oxo-6,8,11,14-eicosatetraenoic acid by human platelets. Blood. 1999 Feb 1;93(3):1086-96.
7 Metabolism and biologic effects of 5-oxoeicosanoids on human neutrophils. J Immunol. 1996 Jan 1;156(1):336-42.
8 A biased ligand for OXE-R uncouples Galpha and Gbetagamma signaling within a heterotrimer. Nat Chem Biol. 2012 Jul;8(7):631-8.
9 Receptors for the 5-oxo class of eicosanoids in neutrophils. J Biol Chem. 1998 Dec 4;273(49):32535-41.